trending Market Intelligence /marketintelligence/en/news-insights/trending/GpKZ_1Cl6EHAHkZZxzP_VA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

AmerisourceBergen fiscal Q3 income up YOY

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


AmerisourceBergen fiscal Q3 income up YOY

AmerisourceBergen Corp. booked $317.7 million in adjusted net income for the fiscal third-quarter ended June 30, up 1.8% year over year.

On a per-share basis, the result — $1.43 — was up 4.4% year over year and compared to the S&P Capital IQ normalized EPS consensus estimate of $1.37.

The healthcare distributor saw its fiscal third-quarter revenue increase by 4.9% year over year to $38.71 billion. Fiscal third-quarter adjusted operating income of $471.1 million was down 4.9% year over year owing to an increase in operating expenses.

On a GAAP basis, the company's fiscal third-quarter net income of $50.4 million was down 85.6% year over year from $349.2 million a year ago.

The Pennsylvania-based company raised the lower end of its adjusted EPS guidance by 5 cents to a range of $5.82 to $5.92.

The S&P Capital IQ normalized EPS consensus estimate for fiscal 2017 is $5.86.